Do higher MPV, ferritin, and an omega-6-skewed fatty-acid ratio point to greater inflammatory mediator tone?

Systemic inflammatory tone is modulated by an intricate interplay between membrane lipid composition, cellular activation, and circulating acute-phase reactants.

Thrombo-inflammatory indicators

• Mean Platelet Volume (MPV): Elevated MPV serves as a validated surrogate marker for platelet activation. Larger, younger platelets contain a higher density of intracellular granules and exhibit heightened pro-thrombotic and metabolic activity.
• Serum Ferritin: Beyond iron storage, ferritin acts as an acute-phase reactant. Circulating levels are directly upregulated by inflammatory cytokines (such as IL-6) and positively correlate with high-sensitivity C-reactive protein (hs-CRP), reflecting subclinical, low-grade systemic inflammatory activity.

Mechanistic convergence

• Lipid Pathway Biasing: An omega-6-skewed fatty acid ratio, characterized by a high arachidonic acid to eicosapentaenoic acid (AA/EPA) ratio, enriches membrane lipid pools. This biases the cyclooxygenase (COX) and lipoxygenase (LOX) pathways toward highly active 2-series eicosanoids (such as PGE2, LTB4, and thromboxane A2 [TXA2]) rather than less active 3-series eicosanoids and resolvins.
• Amplification Cascade: This lipid profile directly promotes platelet activation by shifting eicosanoid synthesis toward pro-aggregatory TXA2. Concurrently, low-grade inflammatory cytokines further stimulate platelet reactivity. Activated platelets then form platelet-monocyte aggregates, prompting monocytes to release potent pro-inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6). This cooperative feedback loop converges to drive a sustained, elevated systemic inflammatory mediator tone.

Bottom line

• Elevated MPV and ferritin, alongside an omega-6-skewed AA/EPA ratio, converge biochemically and cellularly to amplify and sustain systemic inflammatory mediator tone through cooperative eicosanoid and cytokine pathways.